Monthly injection to halt breast cancer is rejected by NHS watchdog despite accepting it can pause the disease for three months longer than other treatments



A monthly injection that halts the course of breast cancer is set to be rejected by health officials.
NHS rationing watchdog NICE today publishes a draft decision rejecting the use of cancer drug fulvestrant.
Officials accept that the £7,900-a-year therapy pauses the growth of a certain form of breast cancer for three months longer than existing treatments. But they insisted there was no evidence that this would save lives.
The watchdog may reverse its decision when it publishes its final guidance later this year. If it does so, 1,200 women in England with advanced... read more

 
1 September 2017 in Health, Views: 60
Source: Daily Mail
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
            1 2 3
    4 5 6 7 8 9 10
    11 12 13 14 15 16 17
    18 19 20 21 22 23 24
    25 26 27 28 29 30